These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14520125)

  • 1. Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study.
    Wallaschofski H; Eigenthaler M; Kiefer M; Donné M; Hentschel B; Gertz HJ; Lohmann T
    J Clin Psychopharmacol; 2003 Oct; 23(5):479-83. PubMed ID: 14520125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in platelet activation by prolactin and leptin.
    Wallaschofski H; Kobsar A; Sokolova O; Siegemund A; Stepan H; Faber R; Eigenthaler M; Lohmann T
    Horm Metab Res; 2004 Jul; 36(7):453-7. PubMed ID: 15305227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin receptor signaling during platelet activation.
    Wallaschofski H; Kobsar A; Koksch M; Siegemund A; Hentschel B; Tuschy U; Lohmann T; Sokolova O; Eigenthaler M
    Horm Metab Res; 2003 Apr; 35(4):228-35. PubMed ID: 12778366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced platelet activation by prolactin in patients with ischemic stroke.
    Wallaschofski H; Lohmann T; Hild E; Kobsar A; Siegemund A; Spilcke-Liss E; Hentschel B; Stumpf C; Daniel WG; Garlichs CD; Eigenthaler M
    Thromb Haemost; 2006 Jul; 96(1):38-44. PubMed ID: 16807649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRL as a novel potent cofactor for platelet aggregation.
    Wallaschofski H; Donné M; Eigenthaler M; Hentschel B; Faber R; Stepan H; Koksch M; Lohmann T
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5912-9. PubMed ID: 11739463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prolactin on platelet activation and blood clotting.
    Wahlberg J; Tillmar L; Ekman B; Lindahl TL; Landberg E
    Scand J Clin Lab Invest; 2013 Apr; 73(3):221-8. PubMed ID: 23570413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
    Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
    J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
    Poyraz BC; Aksoy C; Balcioğlu I
    Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-activation of platelets by prolactin or leptin--pathophysiological findings and clinical implications.
    Wallaschofski H; Kobsar A; Sokolova O; Eigenthaler M; Lohmann T
    Horm Metab Res; 2004 Jan; 36(1):1-6. PubMed ID: 14983399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
    Nakajima M; Terao T; Iwata N; Nakamura J
    Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism due to antipsychotic drug therapy.
    Hägg S; Jönsson AK; Spigset O
    Expert Opin Drug Saf; 2009 Sep; 8(5):537-47. PubMed ID: 19569978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia and atypical antipsychotic therapy in a case of fatal thromboembolism.
    Rousseau AM
    J Clin Psychopharmacol; 2010 Dec; 30(6):734-5. PubMed ID: 21057237
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression.
    Raaz D; Wallaschofski H; Stumpf C; Yilmaz A; Cicha I; Klinghammer L; Daniel WG; Lohmann T; Garlichs CD
    Horm Metab Res; 2006 Nov; 38(11):767-72. PubMed ID: 17111306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study.
    Lacut K; Le Gal G; Couturaud F; Cornily G; Leroyer C; Mottier D; Oger E
    Fundam Clin Pharmacol; 2007 Dec; 21(6):643-50. PubMed ID: 18034665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotic-induced symptomatic hyperprolactinemia: clinical consequences and therapeutic strategies].
    Pollice R; Di Giovambattista E; Tomassini A; Di Pucchio A; Ussorio D; Roncone R; Casacchia M
    Clin Ter; 2007; 158(2):173-9. PubMed ID: 17566521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
    Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroprolactinemia, like hyperprolactinemia, may promote platelet activation.
    Anaforoglu I; Ertorer ME; Kozanoglu I; Unal B; Haydardedeoglu FE; Bakiner O; Bozkirli E; Tutuncu NB; Demirag NG
    Endocrine; 2010 Apr; 37(2):294-300. PubMed ID: 20960266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences.
    Maguire GA
    J Clin Psychiatry; 2002; 63 Suppl 4():56-62. PubMed ID: 11913677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.